Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

Treatment decisions after diagnosis of clinically localised prostate cancer are difficult due to variability in tumour behaviour. We therefore examined one of the most promising biomarkers in prostate cancer, Ki-67, in a cohort of 808 patients diagnosed with prostate cancer between 1990 and 1996 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Berney, D M, Gopalan, A, Kudahetti, S, Fisher, G, Ambroisine, L, Foster, C S, Reuter, V, Eastham, J, Moller, H, Kattan, M W, Gerald, W, Cooper, C, Scardino, P, Cuzick, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661778/
https://www.ncbi.nlm.nih.gov/pubmed/19293807
http://dx.doi.org/10.1038/sj.bjc.6604951

Ejemplares similares

Ejemplares similares